Lite Strategy, Inc. Stock Issued During Period, Shares, Purchase of Assets
Lite Strategy, Inc. (LITS) reported Stock Issued During Period, Shares, Purchase of Assets of 195.76 thousand shares for the 1-month period ending 2012-08-31, per its 10-Q filed 2017-05-04.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets · last filed 2017-09-05
- 2012-08-31: Stock Issued During Period, Shares, Purchase of Assets 1 month 195.76K shares.
- 2012-08-22: Stock Issued During Period, Shares, Purchase of Assets 195.76K shares; Stock Issued During Period, Shares, Purchase of Assets 1 month 195.76K shares; Stock Issued During Period, Shares, Purchase of Assets 1 month as first filed 1.17M shares.
| Period end | Stock Issued During Period, Shares, Purchase of Assets | Stock Issued During Period, Shares, Purchase of Assets 1 month | Stock Issued During Period, Shares, Purchase of Assets 1 month as first filed |
|---|---|---|---|
| 2012-08-31 | 195.76K shares 10-Q · filed 2017-05-04 | ||
| 2012-08-22 | 195.76K shares 10-K · filed 2017-09-05 | 195.76K shares 10-Q · filed 2013-11-08 | 1.17M shares 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |